Lilly Collaborates with Verge Genomics to Develop ALS Therapies

By Ashish Tripathi

Pharma Deals Review: Vol 2021 Issue 9 (Table of Contents)

Published: 14 Sep-2021

DOI: 10.3833/pdr.v2021.i9.2635     ISSN: 1756-7874

Section: Research & Development



In a bid to bolster its neuroscience pipeline, Eli Lilly has entered in a research collaboration agreement to discover, develop and commercialise new therapies for the treatment of amyotrophic lateral sclerosis (ALS)...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details